Cargando…
Applying circulating tumor DNA methylation in the diagnosis of lung cancer
Lung cancer is the leading cause of cancer-related deaths worldwide. Low dose computed tomography (LDCT) is commonly used for disease screening, with identified candidate cancerous regions further diagnosed using tissue biopsy. However, existing techniques are all invasive and unavoidably cause mult...
Autores principales: | Li, Lei, Fu, Kai, Zhou, Wenyu, Snyder, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985769/ https://www.ncbi.nlm.nih.gov/pubmed/35694699 http://dx.doi.org/10.1093/pcmedi/pbz003 |
Ejemplares similares
-
Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021) -
Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021) -
Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring
por: ALEMZADEH, EFFAT, et al.
Publicado: (2023) -
Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015) -
Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)